So you made a baseline correction and now the team discusses ANCOVA [General Sta­tis­tics]

posted by martin  – Austria, 2018-02-15 18:14 (2318 d 19:24 ago) – Posting: # 18424
Views: 4,765

Dear Everbody,

Dealing with endogenous compounds is tricky and here are some more thoughts you may find helpful

This could be considered as change from baseline problem and you may have a look at Stephen Senns work on this topic relating to ANCOVA (e.g. Statist. Med. 2006; 25:4334–4344. )

You may find also this article of interest addressing adjustment of endogenous levels in PK modeling: Bauer, A. & Wolfsegger, M.J. Eur J Clin Pharmacol (2014) 70: 1465.

Best regards & hope this helps


Complete thread:

UA Flag
 Admin contact
23,059 posts in 4,841 threads, 1,649 registered users;
40 visitors (0 registered, 40 guests [including 6 identified bots]).
Forum time: 14:39 CEST (Europe/Vienna)

There are only two kinds of scholars;
those who love ideas and those who hate them.    Emile Chartier

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz